Strong domestic offset by export collapse, prior guidance missed

Revenue +6.8% YoY misses prior FY27 double-digit guidance; growth from pre-placement and mix-shift

Domestic B2C +19% but driven by aggressive pre-placement and liquidation efforts, not organic demand

Only 5% price growth; market did not accept increases until May-end/June; selective pass-through

Seeds +6% YoY, all price-driven; volume under pressure from cotton acreage collapse (-25-35%)

CSM +191% but from tiny base (₹8 to ₹24 Cr); MD admits 'slow burn' requiring years to scale

Exports -28% due to Chinese pricing pressure on acephate, weak Europe/Brazil demand

Prior call: 'double-digit revenue growth' for FY27. Q1 call: 'industry expected to grow 6-8%' (agrochemicals), implying full-year is lower than guided

Prior: 'high double-digit growth in seeds business'. Now: 'mid-to-high single digits minus cotton' due to cotton acreage collapse and shift to rice/maize

North cotton acreage -25%, South/Central -35%, illegal HTBT spread; MD now guides 'flat cotton year' vs prior expectation of growth

Q1 exports -28%; MD acknowledges Chinese competition on catalogues is structural. CSM ramp ('slow burn') will take years vs near-term boost assumed

Prior guidance 'stable-to-soft' margins; delivered 18.3% OPM and 18% EBITDA margin (184 Cr / 1022 Cr) = aligned. No surprise.

MD: price increases 'generally very difficult' mid-season; selective pass-through; will depend on competitive intensity. Implies margin pressure if volumes soft

CSM is okay due to contracts. Catalogues under pressure, especially acephate (raw material from China). Other products (Pendy, metribuzin, hexaconazole) still competitive. CSM ramp slow but progressing; 3-4 products in pipeline over 3 years.

Cotton likely flat year; pivoting focus to rice, maize, millet. North cotton down 25%, illegal HTBT spread in South. But markets sometimes rain even with lower acreage if farmers can spray; too early to predict September-October rain.

Rainfall 15% below normal; but 50% of area irrigated. Delayed sowing but catch-up happening. Farmers shifting to pulses/oilseeds but cotton/groundnut down. Crop shift varies by region. 90-95% of acreage likely planted even in worst case.

Very difficult to predict. Depending on rainfall distribution, lower acreage with good spray windows may offset via higher spray intensity. Too early to call until mid-August.

Selective pass-through; some full, some partial, some none. Price increases hard mid-season. Market acceptance only in June after March cost uptick. Focus now on volume/market share, not further price hikes.

Normalized now; was worse a month ago. Product mix shifting (pre-emergent to post-emergent herbicides in soybean). Being cautious on return provisioning; accounting more rather than less given uncertainty.

Brand strength. Portfolio R&D focus (narrowed to 5 seed crops, stopped GM/vegetable seeds). Enhanced digital/customer outreach. Soil & plant health organic capability build. Target: 500 bps EBITDA margin expansion over 5 years; on track.

Focused on 5 strategic seed crops only; stopped vegetable/GM crops. Portfolio dept strengthened; added product dev layer between marketing/R&D/sales for rigor. B2B team for global collaborations.

Double-edged (buy raw material in dollars). But net exporter; net-net positive. Despite lower export volume, profitability contribution grown. Competitive pressure from Chinese remains product-specific.

Chilli important contributor; product-specific (Cluster) suffered last year due to low commodity prices. This year chilli planting positive with high prices; recovery expected in Q2-Q3. Sugarcane broadly positive if water available.

Depends. Lower acreage with open spray window may offset via higher intensity. Farmers will protect if commodity prices firm up. Situational; too early to predict.

Smaller segment but more profitable. Q1 grew 10% despite slow sowing. Expect faster pickup as sowing accelerates; positive regulatory environment; no portfolio constraints.

Unpredictable. Companies carry forward 30-50% next-year cotton seed inventory (no challenge). Other crops planted October-April. Seed industry has excess this year; should help next season.

₹35 Cr reversal: ₹10-11 Cr recurring (Q1 performance incentive settlement), ₹24 Cr non-recurring (restructuring/retiral). Underlying cost increase ~12% (normal inflation). Non-recurring won't repeat.

Fair to assume pricing power will offset volume drag. Market balanced; no panic. Price increase alone should deliver 6-8%. Unless oversupply/discounting panic emerge.

Fertilizer shortage panic-buying blocked farmer cash; rationing of other inputs. Industry-wide. Collection cycles smooth but cash conversion longer.

Cotton seed North India taken back in Q1 itself. Crop/product-specific. Pre-emergence herbicides for rice, soybean, groundnut taken back in kharif. Normal practice; no point leaving unsold inventory.

Plant-specific; will ask Chirjeev to follow up with details.

Direct seeded rice increases pre/post-emergence consumption. We launched new rice herbicide and in-licensing direct seeded rice tech. Pilot sales in Chhattisgarh; participating in segment.

2 years ago we said herbicide was weakness. Now Q1 herbicide is largest category contributor (+12%); largest followed by insecticide/fungicide. Actively adding products.

Yes, procured for kharif due to war uncertainty and daily price spikes. Can't quantify until season end (different costs mixed). Had cash to negotiate better discounts. Should have positive impact overall.

Price increases not accepted until May-end/June; earlier in quarter there was zero market realization. June saw liquidation of March-stocked material at new prices. Combination of volume and price is helping us.

Normal levels. Initially looked inactive but delayed monsoon gave them extra time. Not sitting on high inventory industry-wide; normal levels.

Regional constraints (Vidarbha: either cotton or soybean). Shift also commodity/rainfall driven. If more soybean: more herbicide, less insecticide. If cotton: less herbicide, more insecticide/fungicide. Farmers' logic varies by crop.

Pricing power expected to deliver 6-8% growth despite lower acreage; assumes no panic discounting; market balanced

Cotton flat/slightly negative; rice, maize, millet driving growth; subject to kharif rainfall and farmer cash recovery

Only ₹24 Cr this quarter from ₹8 Cr; MD admits 'slow burn' requiring sustained cultivation; no near-term material impact expected

Q1 delivered 18% EBITDA (184 Cr / 1022 Cr); mix shift and pricing offsetting cost inflation; but working capital drag and volume uncertainty remain

100 bps per year improvement via R&D, portfolio premiumization, seed/soil & plant health expansion; long-term, not near-term

No specific capex numbers provided; MD deferred to Chirjeev for plant-by-plant detail; incremental sales from prior capex unclear

Rainfall 15% below normal as of July 8; IMD forecast ~90% LPA with model error ±4%; regional deficits in east/northeast/south; sowing lagging -23% YoY; volume recovery highly uncertain

North India cotton -25% acreage; South/Central -35%; illegal HTBT cotton spread; company historically heavy on cotton both seeds and crop protection; expected flat/negative cotton year vs prior growth assumption

Exports -28% YoY; Chinese APIs undercutting on acephate, pendy, hexaconazole in Brazil/US/Europe; CSM ramp slow (described as 'slow burn'); contract manufacturing only bright spot but at scale of ₹24 Cr vs ₹110 Cr export base

Working capital +15-20 days vs prior year due to fertilizer shortage panic-buying blocking farmer cash; inventory still elevated vs prior year; return provisions uncertain given crop volatility; cash conversion cycle elongated

Prior FY27 guidance was 'double-digit revenue growth'; Q1 delivered 6.8% YoY, forcing downgrade to 'industry 6-8%' mid-call. Seeds downgraded from 'high double-digit' to 'mid-to-high single digits minus cotton'. Risk that further misses emerge if monsoon/kharif underperforms